Filtros de búsqueda

Lista de obras de

A Phase II Clinical Trial of Topotecan in Japanese Patients with Relapsed Ovarian Carcinoma ⬇️

artículo científico publicado el 25 de octubre de 2010

A Randomized Phase II/III Trial of 3 Weekly Intraperitoneal versus Intravenous Carboplatin in Combination with Intravenous Weekly Dose-dense Paclitaxel for Newly Diagnosed Ovarian, Fallopian Tube and Primary Peritoneal Cancer ⬇️

artículo científico publicado el 11 de octubre de 2010

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Assess Efficacy and Safety of Weekly Farletuzumab in Combination With Carboplatin and Taxane in Patients With Ovarian Cancer in First Platinum-Sensitive Relapse

artículo científico publicado en 2016

A feasibility study on biweekly administration of docetaxel for patients with recurrent ovarian cancer

artículo científico publicado en 2003

A phase 2 study of intraperitoneal carboplatin plus intravenous dose-dense paclitaxel in front-line treatment of suboptimal residual ovarian cancer

artículo científico publicado en 2020

A phase I study of farletuzumab, a humanized anti-folate receptor α monoclonal antibody, in patients with solid tumors

artículo científico publicado en 2014

A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study

artículo científico publicado en 2011

A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study)

scientific article published on 24 May 2019

A randomized phase II non-comparative study of PF-04691502 and gedatolisib (PF-05212384) in patients with recurrent endometrial cancer

artículo científico publicado en 2016

Adenocarcinoma of the uterine cervix: why is it different?

artículo científico publicado en 2014

Advanced Mucinous Adenocarcinoma Arising from a Mature Cystic Teratoma: A Case Report and Literature Review

artículo científico publicado en 2016

Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial

artículo científico publicado en 2014

Anti-tumor activity of dual inhibition of phosphatidylinositol 3-kinase and MDM2 against clear cell ovarian carcinoma

scientific article published on 05 September 2019

Applicability of the concept of “platinum sensitivity” to recurrent endometrial cancer: The SGSG-012/GOTIC-004/Intergroup study

scientific article published on 25 September 2013

Avelumab (anti-PD-L1) in platinum-resistant/refractory ovarian cancer: JAVELIN Ovarian 200 Phase III study design

artículo científico publicado en 2018

Benign and malignant tumor of the uterine body with broccoli sign: MR imaging features for differential diagnosis

artículo científico

Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial

artículo científico publicado en 2017

COVID 19 vaccination lessons from Japanese anti-HPV vaccination lobby

artículo científico publicado en 2020

Carboplatin dosing in obese women with ovarian cancer: a Gynecologic Oncology Group study

artículo científico publicado en 2008

Characterization of T cell repertoire of blood, tumor, and ascites in ovarian cancer patients using next generation sequencing

artículo científico publicado en 2015

Clinical significance of T cell clonality and expression levels of immune-related genes in endometrial cancer

artículo científico publicado en 2017

Clinical significance of UDP-glucuronosyltransferase 1A1*6 for toxicities of combination chemotherapy with irinotecan and cisplatin in gynecologic cancers: a prospective multi-institutional study

artículo científico publicado en 2009

Clinical trials of neoadjuvant chemotherapy for ovarian cancer: what do we gain after an EORTC trial and after two additional ongoing trials are completed?

artículo científico publicado en 2013

Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma

scientific article published on 31 October 2019

Combination chemotherapy of docetaxel and carboplatin in advanced or recurrent cervix cancer. A pilot study

artículo científico publicado en 2005

Combination chemotherapy with docetaxel and carboplatin for elderly patients with endometrial cancer

artículo científico publicado en 2016

Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy

scientific article published on 22 September 2020

Concordance between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial

artículo científico publicado en 2020

Contemporary management of endometrial cancer

artículo científico

Correction: Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas

artículo científico publicado en 2015

Correlation Between Tumor Mesothelin Expression and Serum Mesothelin in Patients with Epithelial Ovarian Carcinoma: A Potential Noninvasive Biomarker for Mesothelin-targeted Therapy

artículo científico publicado en 2017

Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study.

artículo científico publicado en 2018

Corrigendum to: Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE Registry

artículo científico publicado en 2020

Critical appraisal of bevacizumab in the treatment of ovarian cancer

artículo científico publicado en 2015

Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009

artículo científico publicado en 2010

Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus.

artículo científico publicado en 2015

Difference of carboplatin clearance estimated by the Cockroft-Gault, Jelliffe, Modified-Jelliffe, Wright or Chatelut formula

artículo científico publicado en 2005

Dose-dense chemotherapy and neoadjuvant chemotherapy for ovarian cancer

artículo científico publicado en 2012

Early detection and successful treatment of Wernicke encephalopathy in a patient with advanced carcinoma of the external genitalia during chemotherapy

artículo científico publicado en 2015

Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors: The ALIENOR/ENGOT-ov7 Randomized Clinical Trial

scientific article published on 08 October 2020

Effect of lymphovascular space invasion on survival of stage I epithelial ovarian cancer

artículo científico publicado en 2014

Endocervical adenomyoma

artículo científico publicado en 2008

Erratum: Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression

artículo científico publicado en 2017

Evaluation of Circulating Tumor DNA in Patients with Ovarian Cancer Harboring Somatic PIK3CA or KRAS Mutations

artículo científico publicado en 2020

Evaluation of endometrial cytology: cytohistological correlations in 1,441 cancer patients

artículo científico publicado en 2014

Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition.

artículo científico publicado en 2010

Expression of multiple immune checkpoint molecules on T cells in malignant ascites from epithelial ovarian carcinoma.

artículo científico publicado en 2018

Feasibility and response to nedaplatin monotherapy in older patients with ovarian cancer.

artículo científico publicado en 2017

Feasibility of extraperitoneal laparoscopic para-aortic and common iliac lymphadenectomy

artículo científico publicado en 2006

Feasibility study of combination chemotherapy with paclitaxel, doxorubicin and cisplatin without prophylactic granulocyte colony-stimulating factor injection for intermediate-to-high risk or recurrent endometrial cancer

artículo científico publicado en 2014

Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2.

artículo científico publicado en 2016

First-line intraperitoneal carboplatin-based chemotherapy for 165 patients with epithelial ovarian carcinoma: results of long-term follow-up

artículo científico publicado en 2003

First-line therapy in ovarian cancer trials.

artículo científico publicado en 2011

Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'.

artículo científico publicado en 2004

Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma

artículo científico publicado en 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix.

artículo científico publicado en 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix.

artículo científico publicado en 2014

High expression of maternal embryonic leucine-zipper kinase (MELK) impacts clinical outcomes in patients with ovarian cancer and its inhibition suppresses ovarian cancer cells growth ex vivo

artículo científico publicado en 2020

Identification of serum cytokine clusters associated with outcomes in ovarian clear cell carcinoma

artículo científico publicado en 2020

Immunogenomic landscape of gynecologic carcinosarcoma

scientific article published on 06 December 2020

Improving cancer outcomes through international collaboration in academic cancer treatment trials

artículo científico publicado en 2009

Incorporation of pazopanib in maintenance therapy of ovarian cancer

artículo científico publicado en 2014

Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas

artículo científico publicado en 2015

Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal

artículo científico publicado en 2005

Intraperitoneal carboplatin-based chemotherapy for epithelial ovarian cancer

artículo científico publicado en 2005

Intraperitoneal treatment in ovarian cancer: the gynecologic oncology group perspective in 2012.

artículo científico

Intravenous/intraperitoneal paclitaxel and intraperitoneal carboplatin in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma: a feasibility study

artículo científico publicado en 2012

Landscape of systemic therapy for ovarian cancer in 2019: Primary therapy

scientific article published on 01 December 2019

MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.

artículo científico publicado en 2016

MLH1 Is a Prognostic Biomarker for Serous Ovarian Cancer Treated With Platinum- and Taxane-based Chemotherapy

artículo científico publicado en 2019

MR imaging of polypoid endometriosis of the ovary

artículo científico publicado en 2012

Management of Stage IIB Cervical Cancer: an Overview of the Current Evidence

artículo científico publicado en 2020

Mesonephric adenocarcinoma with a sarcomatous component, a notable subtype of cervical carcinosarcoma: a case report and review of the literature

artículo científico publicado en 2013

Neoadjuvant chemotherapy with docetaxel and carboplatin followed by radical hysterectomy for stage IB2, IIA2, and IIB patients with non-squamous cell carcinoma of the uterine cervix

artículo científico publicado en 2016

Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma

artículo científico publicado en 2020

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

scientific article published on 01 December 2019

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

artículo científico publicado en 2017

PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapy

scientific article published on 01 August 2002

Paradigm Shift in the Management Strategy for Epithelial Ovarian Cancer

artículo científico publicado en 2016

Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study

scientific article published on January 2017

Pembrolizumab monotherapy in Japanese patients with advanced ovarian cancer: Subgroup analysis from the KEYNOTE-100

artículo científico publicado en 2020

Pharmacokinetics of a new fentanyl tape with a novel delivery system of transdermal matrix patches in patients with cancer pain

artículo científico publicado en 2013

Phase 1 dose-escalation study of single-agent veliparib in Japanese patients with advanced solid tumors

artículo científico publicado en 2017

Phase I Study of Multiple Epitope Peptide Vaccination in Patients With Recurrent or Persistent Cervical Cancer

artículo científico publicado en 2018

Phase II clinical trial of pegylated liposomal doxorubicin (JNS002) in Japanese patients with mullerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of fallopian tube, peritoneal carcinoma) having a therapeutic history of platinum-base

artículo científico publicado en 2008

Phase II study of combination chemotherapy with docetaxel and carboplatin for locally advanced or recurrent cervical cancer

artículo científico publicado el 1 de diciembre de 2010

Phase II study of intraperitoneal carboplatin with intravenous paclitaxel in patients with suboptimal residual epithelial ovarian or primary peritoneal cancer: a Sankai Gynecology Cancer Study Group Study

artículo científico publicado en 2009

Phase III double-blind randomized trial of radiation therapy for stage IIIb cervical cancer in combination with low- or high-dose Z-100: treatment with immunomodulator, more is not better

artículo científico publicado en 2005

Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer

artículo científico publicado en 2018

Platelet-sparing effect of paclitaxel in heavily pretreated ovarian cancer patients

artículo científico publicado en 2002

Point: Is There Still a Role for Intraperitoneal Platinum Therapy in Ovarian Cancer?

artículo científico publicado en 2018

Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression

artículo científico publicado en 2017

Predicting toxicity of platinum and taxane-based chemotherapy in older patients with gynecologic cancer

artículo científico publicado en 2020

Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218

artículo científico publicado en 2020

Principle and evolving role of intraperitoneal chemotherapy in ovarian cancer

artículo científico

Principles of chemotherapy

artículo científico publicado en 2015

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial

artículo científico publicado en 2016

Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

scientific article published on 19 April 2019

Randomized phase II study of immunomodulator Z-100 in patients with stage IIIB cervical cancer with radiation therapy

artículo científico publicado en 2006

Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m² versus 40 mg/m² in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial

artículo científico publicado en 2020

SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study

scientific article published on 20 March 2019

Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer

artículo científico publicado en 2019

Serum folate receptor alpha as a biomarker for ovarian cancer: Implications for diagnosis, prognosis and predicting its local tumor expression

artículo científico publicado en 2015

Single nedaplatin treatment as salvage chemotherapy for platinum/taxane‐resistant/refractory epithelial ovarian, tubal and peritoneal cancers ⬇️

artículo científico publicado el 1 de agosto de 2010

Splenectomy during secondary cytoreductive surgery for epithelial ovarian cancer

artículo científico publicado el 1 de enero de 2010

Spontaneously Ruptured Endometrioma Associated with Endometrioid Adenocarcinoma: MR Findings ⬇️

artículo científico publicado el 1 de enero de 2010

Squamous cell carcinoma of the uterine cervix in association with stage 0 chronic lymphocytic leukemia/small lymphocytic lymphoma

artículo científico publicado en 2004

Subclinical thiamine deficiency identified by preoperative evaluation in an ovarian cancer patient: Diagnosis and the need for preoperative thiamine measurement

scientific article published on 01 October 2019

Surgical and systemic management of endometrial cancer: an international survey

artículo científico publicado en 2014

Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion.

artículo científico

T-LAK Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Ovarian Cancer

artículo científico publicado en 2016

Targeted therapy in gynecologic cancers: Ready for prime time?

artículo científico publicado en 2015

The Efficacy of Low-Dose Paclitaxel Added to Combination Chemotherapy of Carboplatin and Gemcitabine or Pegylated Liposomal Doxorubicin

artículo científico publicado en 2016

The Risk of Ovarian Malignancy Algorithm (ROMA) as a Predictive Marker of Peritoneal Dissemination in Epithelial Ovarian Cancer Patients.

artículo científico publicado en 2015

The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma.

artículo científico publicado en 2017

The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG

artículo científico publicado en 2020

Three ongoing intraperitoneal chemotherapy trials in ovarian cancer

artículo científico publicado en 2012

Tolerability and Efficacy of Bevacizumab Monotherapy in Older Patients With Recurrent Ovarian Cancer

artículo científico publicado en 2020

Treatment Outcome of Second-Line Chemotherapy for Gynecologic Carcinosarcoma

artículo científico publicado en 2020

Tumor-related mutations in cell-free DNA in pre-operative plasma as a prognostic indicator of recurrence in endometrial cancer

artículo científico publicado en 2020

Two viral infections in Japan

artículo científico publicado en 2020

Unusual MR findings in ovarian leiomyoma

artículo científico publicado en 2013

Use of IP chemotherapy in ovarian cancer: the critical questions

artículo científico publicado el 1 de febrero de 2011

Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE Registry

artículo científico publicado en 2020

Venous thromboembolism in patients with cancer: design and rationale of a multicentre, prospective registry (Cancer-VTE Registry).

artículo científico publicado en 2018

Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma.

artículo científico publicado en 2015

Weekly administration of temsirolimus for heavily pretreated patients with clear cell carcinoma of the ovary: a report of six cases

artículo científico publicado en 2011

What is an appropriate second-line regimen for recurrent endometrial cancer? Ancillary analysis of the SGSG012/GOTIC004/Intergroup study.

artículo científico publicado en 2015

[Combination Therapy of Pregabalin with Tramadol for Treatment of Peripheral Neuropathy in Patients with Gynecological Cancer Receiving Taxane Containing Chemotherapy].

artículo científico publicado en 2017

[Current Status and Future Perspectives of Chemotherapy for Gynecologic Cancers]

artículo científico publicado en 2017

[Current and future trend of chemotherapy for ovarian cancer]

[Current topic of intraperitoneal infusions for treatment of ovarian cancer]

scientific article published on 01 February 2008

[Future Perspectives in Treatment of Ovarian Cancer]

scientific article published on 01 February 2016

[Gynecologic Cancer Chemotherapy for Gynecologic Cancer 2020]

scientific article published on 01 February 2020

[Gynecologic Cancer Controversies in Gynecologic Cancer Surgery]

scientific article published on 01 February 2019

[Gynecologic Tumor Chemotherapy for Rare Tumors in Gynecologic Malignancies]

[I. Clinical Development and Prospect of Chemotherapy for Uterine Carcinosarcoma]

[II. Future perspectives of intraperitoneal chemotherapy for ovarian cancer]

artículo científico publicado en 2014

[Intraperitoneal chemotherapy]

artículo científico publicado en 2012

[Poly (ADP-Ribose) Polymerase Inhibitors--Current Status and Future Developments].

artículo científico publicado en 2016

[Treatment of vulvar cancer--updated information]

scientific article published on 01 August 2002

p16INK4a expression in cytology of ascites and response to chemotherapy in advanced ovarian cancer

artículo científico publicado en 2009

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda